Ketogenic diet restrains aging-induced exacerbation of coronavirus infection in mice

  1. Seungjin Ryu
  2. Irina Shchukina
  3. Yun-Hee Youm
  4. Hua Qing
  5. Brandon Hilliard
  6. Tamara Dlugos
  7. Xinbo Zhang
  8. Yuki Yasumoto
  9. Carmen J Booth
  10. Carlos Fernández-Hernando
  11. Yajaira Suárez
  12. Kamal Khanna
  13. Tamas L Horvath
  14. Marcelo O Dietrich
  15. Maxim N Artyomov
  16. Andrew Wang  Is a corresponding author
  17. Vishwa Deep Dixit  Is a corresponding author
  1. Yale University, United States
  2. Washington University School of Medicine, United States
  3. Yale University School of Medicine, United States
  4. New York University Langone Health, United States
  5. Yale School of Medicine, United States

Abstract

Increasing age is the strongest predictor of risk of COVID-19 severity and mortality. Immunometabolic switch from glycolysis to ketolysis protects against inflammatory damage and influenza infection in adults. To investigate how age compromises defense against coronavirus infection, and whether a pro-longevity ketogenic-diet (KD) impacts immune-surveillance, we developed an aging model of natural murine beta coronavirus (mCoV) infection with mouse hepatitis virus strain-A59 (MHV-A59). When inoculated intranasally, mCoV is pneumotropic and recapitulates several clinical hallmarks of COVID-19 infection. Aged mCoV-A59-infected mice have increased mortality and higher systemic inflammation in the heart, adipose tissue and hypothalamus, including neutrophilia and loss of γδ T cells in lungs. Activation of ketogenesis in aged mice expands tissue protective γδ T cells, deactivates the NLRP3 inflammasome and decreases pathogenic monocytes in lungs of infected aged mice. These data establish harnessing of the ketogenic immunometabolic checkpoint as a potential treatment against coronavirus infection in the aged.

Data availability

The single cell RNA-sequencing and bulk RNA-sequencing data has been uploaded to Gene Expression Omnibus (GSE155346 and GSE155347) respectively.

The following data sets were generated

Article and author information

Author details

  1. Seungjin Ryu

    Comparative Medicine and Immunobiology, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Irina Shchukina

    Pathology and Immunology, Washington University School of Medicine, St. Louis, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Yun-Hee Youm

    Comparative Medicine and Immunobiology, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Hua Qing

    Internal Medicine, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Brandon Hilliard

    Internal Medicine, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Tamara Dlugos

    Comparative Medicine and Immunobiology, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Xinbo Zhang

    Comparative Medicine, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Yuki Yasumoto

    Comparative Medicine, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Carmen J Booth

    Department of Comparative Medicine, Yale University School of Medicine, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Carlos Fernández-Hernando

    Comparative Medicine and Program in Integrative Cell Signaling and Neurobiology of Metabolism, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Yajaira Suárez

    Comparative Medicine and Program in Integrative Cell Signaling and Neurobiology of Metabolism, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Kamal Khanna

    New York University Langone Health, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Tamas L Horvath

    Program in Integrative Cell Signaling and Neurobiology of Metabolism, Yale University School of Medicine, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7522-4602
  14. Marcelo O Dietrich

    Comparative Medicine, Yale University School of Medicine, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9781-2221
  15. Maxim N Artyomov

    Department of Pathology and Immunology, Washington University School of Medicine, St Louis, United States
    Competing interests
    The authors declare that no competing interests exist.
  16. Andrew Wang

    Yale School of Medicine, New Haven, United States
    For correspondence
    andrew.wang@yale.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6951-8081
  17. Vishwa Deep Dixit

    Comparative Medicine and Immunobiology, Yale University School of Medicine, New Haven, United States
    For correspondence
    vishwa.dixit@yale.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5341-6494

Funding

National Institute on Aging (P01AG051459)

  • Vishwa Deep Dixit

National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR070811)

  • Vishwa Deep Dixit

American Federation for Aging Research (Glenn Foundation for Medical Research Postdoctoral Fellowships in Aging Research)

  • Seungjin Ryu

National Institute of Allergy and Infectious Diseases (1K08AI128745)

  • Andrew Wang

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All experiments and animal use were conducted in compliance with the National Institute of Health Guide for the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee (IACUC) protocol (#2019-11572 and 2020-20149) of Yale University.

Copyright

© 2021, Ryu et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 8,065
    views
  • 490
    downloads
  • 39
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Seungjin Ryu
  2. Irina Shchukina
  3. Yun-Hee Youm
  4. Hua Qing
  5. Brandon Hilliard
  6. Tamara Dlugos
  7. Xinbo Zhang
  8. Yuki Yasumoto
  9. Carmen J Booth
  10. Carlos Fernández-Hernando
  11. Yajaira Suárez
  12. Kamal Khanna
  13. Tamas L Horvath
  14. Marcelo O Dietrich
  15. Maxim N Artyomov
  16. Andrew Wang
  17. Vishwa Deep Dixit
(2021)
Ketogenic diet restrains aging-induced exacerbation of coronavirus infection in mice
eLife 10:e66522.
https://doi.org/10.7554/eLife.66522

Share this article

https://doi.org/10.7554/eLife.66522

Further reading

    1. Immunology and Inflammation
    Javier Ruiz-Navarro, Sara Fernández-Hermira ... Manuel Izquierdo Pastor
    Research Article

    We analyzed here how formin-like 1 β (FMNL1β), an actin cytoskeleton-regulatory protein, regulates microtubule-organizing center (MTOC) and multivesicular bodies (MVB) polarization and exosome secretion at an immune synapse (IS) model in a phosphorylation-dependent manner. IS formation was associated with transient recruitment of FMNL1β to the IS, which was independent of protein kinase C δ (PKCδ). Simultaneous RNA interference of all FMNL1 isoforms prevented MTOC/MVB polarization and exosome secretion, which were restored by FMNL1βWT expression. However, expression of the non-phosphorylatable mutant FMNL1βS1086A did not restore neither MTOC/MVB polarization nor exosome secretion to control levels, supporting the crucial role of S1086 phosphorylation in MTOC/MVB polarization and exosome secretion. In contrast, the phosphomimetic mutant, FMNL1βS1086D, restored MTOC/MVB polarization and exosome secretion. Conversely, FMNL1βS1086D mutant did not recover the deficient MTOC/MVB polarization occurring in PKCδ-interfered clones, indicating that S1086 FMNL1β phosphorylation alone is not sufficient for MTOC/MVB polarization and exosome secretion. FMNL1 interference inhibited the depletion of F-actin at the central region of the immune synapse (cIS), which is necessary for MTOC/MVB polarization. FMNL1βWT and FMNL1βS1086D, but not FMNL1βS1086A expression, restored F-actin depletion at the cIS. Thus, actin cytoskeleton reorganization at the IS underlies the effects of all these FMNL1β variants on polarized secretory traffic. FMNL1 was found in the IS made by primary T lymphocytes, both in T cell receptor (TCR) and chimeric antigen receptor (CAR)-evoked synapses. Taken together, these results point out a crucial role of S1086 phosphorylation in FMNL1β activation, leading to cortical actin reorganization and subsequent control of MTOC/MVB polarization and exosome secretion.

    1. Immunology and Inflammation
    2. Microbiology and Infectious Disease
    Bin Li, Jin Zhang ... Chao Wu
    Research Article

    Adjuvants can affect APCs function and boost adaptive immune responses post-vaccination. However, whether they modulate the specificity of immune responses, particularly immunodominant epitope responses, and the mechanisms of regulating antigen processing and presentation remain poorly defined. Here, using overlapping synthetic peptides, we screened the dominant epitopes of Th1 responses in mice post-vaccination with different adjuvants and found that the adjuvants altered the antigen-specific CD4+ T-cell immunodominant epitope hierarchy. MHC-II immunopeptidomes demonstrated that the peptide repertoires presented by APCs were significantly altered by the adjuvants. Unexpectedly, no novel peptide presentation was detected after adjuvant treatment, whereas peptides with high binding stability for MHC-II presented in the control group were missing after adjuvant stimulation, particularly in the MPLA- and CpG-stimulated groups. The low-stability peptide present in the adjuvant groups effectively elicited robust T-cell responses and formed immune memory. Collectively, our results suggest that adjuvants (MPLA and CpG) inhibit high-stability peptide presentation instead of revealing cryptic epitopes, which may alter the specificity of CD4+ T-cell-dominant epitope responses. The capacity of adjuvants to modify peptide–MHC (pMHC) stability and antigen-specific T-cell immunodominant epitope responses has fundamental implications for the selection of suitable adjuvants in the vaccine design process and epitope vaccine development.